Drug & Cancer & Variant
Search content: Tumor = Adenoid Cystic Carcinoma
There are 1 entries with your keyword(s).
Gene Variant Type Tumor Drug Drug level Reference More
NOTCH1 2245-2536 MUT Adenoid Cystic Carcinoma NOTCH1 inhibitors IV 1
Evidence region


Patient Criteria



NOTCH1 mutations define a distinct disease phenotype characterized by solid histology, liver and bone metastasis, poor prognosis, and potential responsiveness to Notch1 inhibitors. Clinical studies targeting Notch1 in a genotype-defined ACC subgroup are warranted.

Gene name


Full name

notch receptor 1

Gene type



This gene encodes a member of the NOTCH family of proteins. Members of this Type I transmembrane protein family share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple different domain types. Notch signaling is an evolutionarily conserved intercellular signaling pathway that regulates interactions between physically adjacent cells through binding of Notch family receptors to their cognate ligands. The encoded preproprotein is proteolytically processed in the trans-Golgi network to generate two polypeptide chains that heterodimerize to form the mature cell-surface receptor. This receptor plays a role in the development of numerous cell and tissue types. Mutations in this gene are associated with aortic valve disease, Adams-Oliver syndrome, T-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, and head and neck squamous cell carcinoma. [provided by RefSeq, Jan 2016]

Sorry, there is no related drug information.

Showing 1 to 1 of 1 entries, entries per page